NCCN Collaborates with Pfizer on Program Focused on Health Care Quality Improvement and Education
NCCN and Pfizer will elicit proposals for quality improvement and education in rare cancer types; Grants to provide funding for approximately nine proposals focused on patients with renal cell carcinoma or hematologic malignanciesFORT WASHINGTON, PA — The National Comprehensive Cancer Network ® (NCCN ®) Oncology Research Program (ORP ) is collaborating with Pfizer Independent Grants for Learning & Change (IGLC) to establish a peer-reviewed